Results 171 to 180 of about 18,215 (242)

Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification. [PDF]

J Gynecol Oncol
Kim JH, Kim DE, Kim U, Bae JK, Jin WH, Park SY, Lim MC.   +6 more
europepmc   +1 more source

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

JAMA Netw Open
Ostrowski M, Jo Y, Hage Chehade C, Ozay ZI, Gebrael G, Sayegh N, Lin E, Srivastava A, Gordhamer A, Ji R, Li H, Mathew Thomas V, Gupta S, Riaz IB, Maughan BL, Roy S, Agarwal N, Swami U.   +17 more
europepmc   +1 more source

Convergent Approach Toward ADP-Ribosylated Peptides via a Chemoselective Phosphate Condensation. [PDF]

Chemistry
Wijngaarden S, van der Heijden FLAM, Bogaart CJ, Siskou M, Tsoumani I, Robinson DJ, van der Marel GA, Codée JDC, Overkleeft HS, Filippov DV.   +9 more
europepmc   +1 more source

Enzymatic synthesis of key RNA therapeutic building blocks using simple phosphate donors. [PDF]

Nat Commun
Meng Q, Benckendorff C, Morrill C, Zhuo Y, Egerström A, Ní Cheallaigh A, Derrington SR, Obexer R, Ortmayer M, Levy CW, Finnigan JD, Charnock SJ, Turner NJ, Miller GJ, Lovelock SL.   +14 more
europepmc   +1 more source

The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]

Purinergic Signal
da Silva FC, Stabile J, Fürstenau CR, Araújo TG.   +3 more
europepmc   +1 more source

Purine Nucleotide Precursors in Preventing Myocardial Ischemia-Reperfusion Injury. [PDF]

Int J Mol Sci
Musial PT, Badtke PA, Zabielska-Kaczorowska MA.   +2 more
europepmc   +1 more source

Recent Progress in Selenium Nanomedicines for Ocular Diseases. [PDF]

Int J Nanomedicine
Jiang B, Zhang L, Hong N, Wen Y, Li A, Shi Y, Dong F.   +6 more
europepmc   +1 more source

Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities. [PDF]

Cancers (Basel)
Cabeza-Fernández V, Ríos-Sola FJ, Martín-Oliva D, Borrego-Pérez J, Oliver FJ, YéLamos J, Rodríguez-Vargas JM.   +6 more
europepmc   +1 more source

Rethinking evidence standards for men with metastatic prostate cancer in the post-androgen receptor pathway inhibitor setting: new insights from CONTACT-02. [PDF]

Transl Androl Urol
Takemura K, Yusasa T.
europepmc   +1 more source

Molecularly Targeted Cancer Medications and Kidney Health.

JAMA Netw Open
Ziolkowski S, Long J, Zhong Y, Morgan-Cooper H, Wakelee H, Khaki A, Riaz F, Reddy S, Leonard M, Anand S.   +9 more
europepmc   +1 more source